115 related articles for article (PubMed ID: 35730811)
1. A detailed multi-omics analysis of GNB2 gene in human cancers.
Zhang L; Sahar AM; Li C; Chaudhary A; Yousaf I; Saeedah MA; Mubarak A; Haris M; Nawaz M; Reem MA; Ramadan FA; Mostafa AAM; Feng W; Hameed Y
Braz J Biol; 2022; 84():e260169. PubMed ID: 35730811
[TBL] [Abstract][Full Text] [Related]
2. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
3. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
[TBL] [Abstract][Full Text] [Related]
4. A Mutation in the G-Protein Gene
Stallmeyer B; Kuß J; Kotthoff S; Zumhagen S; Vowinkel K; Rinné S; Matschke LA; Friedrich C; Schulze-Bahr E; Rust S; Seebohm G; Decher N; Schulze-Bahr E
Circ Res; 2017 May; 120(10):e33-e44. PubMed ID: 28219978
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
6. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of GINS1 highlighted a good diagnostic and prognostic potential of survival in three different subtypes of human cancer.
Ahmad M; Hameed Y; Khan M; Usman M; Rehman A; Abid U; Asif R; Ahmed H; Hussain MS; Rehman JU; Asif HM; Arshad R; Atif M; Hadi A; Sarfraz U; Khurshid U
Braz J Biol; 2021; 84():e250575. PubMed ID: 34852135
[TBL] [Abstract][Full Text] [Related]
8. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
[TBL] [Abstract][Full Text] [Related]
9. DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration.
Xu Y; Jiang Q; Liu H; Xiao X; Yang D; Saw PE; Luo B
J Immunol Res; 2020; 2020():8835393. PubMed ID: 33490290
[TBL] [Abstract][Full Text] [Related]
10. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
[TBL] [Abstract][Full Text] [Related]
12. Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer.
Sial N; Saeed S; Ahmad M; Hameed Y; Rehman A; Abbas M; Asif R; Ahmed H; Hussain MS; Rehman JU; Atif M; Khan MR
Int J Gen Med; 2021; 14():7025-7042. PubMed ID: 34707394
[TBL] [Abstract][Full Text] [Related]
13. Decoding signal transducer and activator of transcription 1 across various cancers through data mining and integrative analysis.
Munir H; Rana AT; Faheem M; Almutairi SM; Siddique T; Asghar S; Abdel-Maksoud MA; Mubarak A; Elkhamisy FAA; Studenik CR; Yaz H
Am J Transl Res; 2022; 14(6):3638-3657. PubMed ID: 35836889
[TBL] [Abstract][Full Text] [Related]
14. Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
Dong Y; Cai Q; Fu L; Liu H; Ma M; Wu X
Biomed Res Int; 2021; 2021():4873678. PubMed ID: 34337013
[TBL] [Abstract][Full Text] [Related]
15. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma.
Wu SY; Liao P; Yan LY; Zhao QY; Xie ZY; Dong J; Sun HT
BMC Gastroenterol; 2021 Nov; 21(1):416. PubMed ID: 34724892
[TBL] [Abstract][Full Text] [Related]
16. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
Kaur H; Bhalla S; Raghava GPS
PLoS One; 2019; 14(9):e0221476. PubMed ID: 31490960
[TBL] [Abstract][Full Text] [Related]
17. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
18. Type-1 Na
Zhou YT; Chen H; Ai M; Li SS; Li BY; Zhao Y; Cai WW; Hou B; Ni LL; Xu F; Qiu LY
Life Sci; 2021 Aug; 278():119613. PubMed ID: 34000263
[TBL] [Abstract][Full Text] [Related]
19. miR-381 Reverses Multidrug Resistance by Negative Regulation of the
Pu B; Yu X; Cao Y; Li Y; Tang L; Xia J
DNA Cell Biol; 2021 Dec; 40(12):1584-1596. PubMed ID: 34931867
[TBL] [Abstract][Full Text] [Related]
20. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma.
Guo ZY; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7238-7251. PubMed ID: 34919223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
